Previous Article | Next Article 
Molecular and Cellular Biology, November 2006, p. 8022-8031, Vol. 26, No. 21
0270-7306/06/$08.00+0 doi:10.1128/MCB.01091-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Notch1 Contributes to Mouse T-Cell Leukemia by Directly Inducing the Expression of c-myc
Vishva Mitra Sharma,1,
Jennifer A. Calvo,1,
,
Kyle M. Draheim,1
Leslie A. Cunningham,1
Nicole Hermance,1
Levi Beverly,2
Veena Krishnamoorthy,1
Manoj Bhasin,3
Anthony J. Capobianco,2 and
Michelle A. Kelliher1*
Department of Cancer Biology and Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts,1
Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts,3
Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania2
Received 16 June 2006/
Returned for modification 17 July 2006/
Accepted 8 August 2006
Recent work with mouse models and human leukemic samples has shown that gain-of-function mutation(s) in Notch1 is a common genetic event in T-cell acute lymphoblastic leukemia (T-ALL). The Notch1 receptor signals through a
-secretase-dependent process that releases intracellular Notch1 from the membrane to the nucleus, where it forms part of a transcriptional activator complex. To identify Notch1 target genes in leukemia, we developed mouse T-cell leukemic lines that express intracellular Notch1 in a doxycycline-dependent manner. Using gene expression profiling and chromatin immunoprecipitation, we identified c-myc as a novel, direct, and critical Notch1 target gene in T-cell leukemia. c-myc mRNA levels are increased in primary mouse T-cell tumors that harbor Notch1 mutations, and Notch1 inhibition decreases c-myc mRNA levels and inhibits leukemic cell growth. Retroviral expression of c-myc, like intracellular Notch1, rescues the growth arrest and apoptosis associated with
-secretase inhibitor treatment or Notch1 inhibition. Consistent with these findings, retroviral insertional mutagenesis screening of our T-cell leukemia mouse model revealed common insertions in either notch1 or c-myc genes. These studies define the Notch1 molecular signature in mouse T-ALL and importantly provide mechanistic insight as to how Notch1 contributes to human T-ALL.
* Corresponding author. Mailing address: Department of Cancer Biology, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 01605. Phone: (508) 856-8620. Fax: (508) 856-1310. E-mail: michelle.kelliher{at}umassmed.edu.
Published ahead of print on 5 September 2006.
V.M.S. and J.A.C. contributed equally to this work.
Present address: Diabetes Division, Novartis, Inc., Cambridge, MA 02139.
Molecular and Cellular Biology, November 2006, p. 8022-8031, Vol. 26, No. 21
0270-7306/06/$08.00+0 doi:10.1128/MCB.01091-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Palomero, T., Ferrando, A.
(2008). Oncogenic NOTCH1 Control of MYC and PI3K: Challenges and Opportunities for Anti-NOTCH1 Therapy in T-Cell Acute Lymphoblastic Leukemias and Lymphomas. Clin. Cancer Res.
14: 5314-5317
[Abstract]
[Full Text]
-
Hsu, K.-W., Hsieh, R.-H., Lee, Y.-H. W., Chao, C.-H., Wu, K.-J., Tseng, M.-J., Yeh, T.-S.
(2008). The Activated Notch1 Receptor Cooperates with {alpha}-Enolase and MBP-1 in Modulating c-myc Activity. Mol. Cell. Biol.
28: 4829-4842
[Abstract]
[Full Text]
-
Lee, C. W., Raskett, C. M., Prudovsky, I., Altieri, D. C.
(2008). Molecular Dependence of Estrogen Receptor-Negative Breast Cancer on a Notch-Survivin Signaling Axis. Cancer Res.
68: 5273-5281
[Abstract]
[Full Text]
-
Van Vlierberghe, P., van Grotel, M., Tchinda, J., Lee, C., Beverloo, H. B., van der Spek, P. J., Stubbs, A., Cools, J., Nagata, K., Fornerod, M., Buijs-Gladdines, J., Horstmann, M., van Wering, E. R., Soulier, J., Pieters, R., Meijerink, J. P. P.
(2008). The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood
111: 4668-4680
[Abstract]
[Full Text]
-
De Keersmaecker, K., Lahortiga, I., Mentens, N., Folens, C., Van Neste, L., Bekaert, S., Vandenberghe, P., Odero, M. D., Marynen, P., Cools, J.
(2008). In vitro validation of {gamma}-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. haematol
93: 533-542
[Abstract]
[Full Text]
-
Wang, S.-F., Aoki, M., Nakashima, Y., Shinozuka, Y., Tanaka, H., Taniwaki, M., Hattori, M., Minato, N.
(2008). Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling. Blood
111: 2878-2886
[Abstract]
[Full Text]
-
O'Neil, J., Tchinda, J., Gutierrez, A., Moreau, L., Maser, R. S., Wong, K.-K., Li, W., McKenna, K., Liu, X. S., Feng, B., Neuberg, D., Silverman, L., DeAngelo, D. J., Kutok, J. L., Rothstein, R., DePinho, R. A., Chin, L., Lee, C., Look, A. T.
(2007). Alu elements mediate MYB gene tandem duplication in human T-ALL. J. Exp. Med.
204: 3059-3066
[Abstract]
[Full Text]
-
Mansour, M. R., Duke, V., Foroni, L., Patel, B., Allen, C. G., Ancliff, P. J., Gale, R. E., Linch, D. C.
(2007). Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia. Clin. Cancer Res.
13: 6964-6969
[Abstract]
[Full Text]
-
Liao, W.-R., Hsieh, R.-H., Hsu, K.-W., Wu, M.-Z., Tseng, M.-J., Mai, R.-T., Wu Lee, Y.-H., Yeh, T.-S.
(2007). The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. Carcinogenesis
28: 1867-1876
[Abstract]
[Full Text]
-
Thompson, B. J., Buonamici, S., Sulis, M. L., Palomero, T., Vilimas, T., Basso, G., Ferrando, A., Aifantis, I.
(2007). The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med.
204: 1825-1835
[Abstract]
[Full Text]
-
O'Neil, J., Grim, J., Strack, P., Rao, S., Tibbitts, D., Winter, C., Hardwick, J., Welcker, M., Meijerink, J. P., Pieters, R., Draetta, G., Sears, R., Clurman, B. E., Look, A. T.
(2007). FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to {gamma}-secretase inhibitors. J. Exp. Med.
204: 1813-1824
[Abstract]
[Full Text]
-
Chan, S. M., Weng, A. P., Tibshirani, R., Aster, J. C., Utz, P. J.
(2007). Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood
110: 278-286
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.